logo
India is showing signs of trusting China again. Beijing sees a window of weakness

India is showing signs of trusting China again. Beijing sees a window of weakness

The Print29-07-2025
Meanwhile, this drip-feed rapprochement is occurring in the backdrop of increasing volley of disagreements between India and its closest strategic partner – the US. Delhi and Washington are in the midst of a significant recalibration of ties and featuring strong (as well as emotive) disagreements over trade, diplomacy (ceasefire claims), secondary sanctions on Russian energy purchases, and arms purchases.
Signs of convergence include an amiable visit by External Affairs Minister S Jaishankar to China for the SCO Foreign Ministers meet, India's seeming willingness to consider the reviving of the Russia-India-China (RIC) mechanism, a government think tank (Niti Aayog) suggesting that Chinese companies could be allowed to acquire up to a 24% stake in Indian firms without prior approval, the resumption of tourism visas and direct flights, and optimistic statements relating to a practical roadmap to make progress towards resolving the boundary dispute from bilateral meets such as the WMCC in July this year as well as Defense Minister Rajnath Singh's visit to China in June.
Recent weeks have seen increasing signs of growing convergence and a deepening thaw in India-China relations. This has occurred despite China's support for Pakistan during Op Sindoor, the initiation of construction on the controversial Yarlung Zangbo dam, as well as an intensification of economic coercion through new regulations on exports, including critical minerals , agricultural inputs , high-speed railways , and electronics . Hence, the deepening thaw—despite China's intensified coercive approach—appears somewhat contradictory, or at least a puzzle.
Episodic warmth: But what's new?
India's episodic tactical pivots towards better ties with China to enhance its bargaining position vis-à-vis the US are not new or unfamiliar. It represents a core feature of Indian multi-alignment (strategic autonomy), whereby India relies on its 'power to switch sides' to extract more beneficial approaches from both adversaries and like-minded partners. Arguably, a similar approach was at work last year when India and China reached a significant patrolling agreement at the LAC, which in turn helped signal to the US that Delhi is 'not geopolitically cornered' and 'has options'.
However, the ongoing tactical pivot does have some new features that are worth noting.
Moment of acute instability in India-US ties
India-US ties are indeed undergoing unprecedented churn, marked by a leverage-based approach by Washington. The US pressure on India to open its key and sensitive sectors to US imports, as well as adopt extensive changes to existing non-tariff barriers, is a new and uncomfortable development. President Trump's ceaseless and frequent references to the use of leverages to enforce a ceasefire on the 10th of May continues to irritate Delhi; while delays and snags related to the supply of GE jet engines has led multiple news reports to suggest that India is or should look at alternatives – ranging from France, to Japan as well as Russia. While initially over-optimistic about a trade agreement (including the strategic implications of the same), Delhi now appears pessimistic and anxious. President Trump's references to the 'Indonesia way' as a model for the deal with India have set off alarm bells in some sections of industry and among experts. Delhi had hoped, since February this year, that providing Trump with a favorable (but still reasonable) trade deal would guarantee the restoration of warmth in India-US ties. However, recent trends (including the threat of Russia-related sanctions as well as perceived US-Pakistan ties) are souring such hopes. Finally, earlier bouts of India-China flirtations were significantly constrained by the structural realities of strategic convergence between India and the US and divergence between China and India. This structural fact, although still formidable, has weakened over the last year or two, and Delhi remains in a state of uncertainty (understandably) about Trump's China policy.
China is poised to reap strategic dividends
India's strategic vulnerability to China at the present moment is unprecedented as well (arguably since 1962). The vulnerability is strikingly multifaceted and leaves India with very little choice (at least in the short term) other than diplomacy, patience, and attempts to generate goodwill in Beijing. China's support for Pakistan and the potential sale of advanced fighter jets represent a strong pressure point. The above-mentioned dam construction represents yet another vulnerability, with Arunachal Pradesh CM describing it as a 'ticking time bomb'.
However, the most acute and immediate vulnerability pertains to China's emerging system of economic coercion. Current opinion is not entirely stable regarding China's motivations. They range from thwarting India's rise to securing China's own strategic sectors from diffusion and potential loss of advantage. In reality, Chinese motivation is likely to be a mix and also consists of diplomatic objectives (bargaining and leverage). More economically minded officials and analysts view such measures as 'retaliation' for India's own economically discriminatory policies aimed at China since 2020 (Press Note 3) and suggest that China is merely 'hitting back' to encourage Delhi to ease restrictions on Chinese companies and investments. Regardless of exact intent, however, what is alarming is the newfound comfort Beijing has found in resorting to such economic arm-twisting. This is entirely new and lacks an established template in terms of cognition and response.
Could this tactical pivot lead to outcomes that are strategic?
There is a long history of India seeking tactical improvement in ties with Beijing from time to time, based on the immediate bilateral and geopolitical context. Hence, such efforts are usually met with both scepticism (regarding sustainability) as well as strategic wariness (towards outcomes). In other words, concerns range from the inherent futility of such efforts as well as the dangers that may emanate from 'trusting' China again.
Even in the present melee, it is hard to decode which aspects of the slow-moving convergence are symbolic, tactical, and purely bilateral, and which aspects are strategic, material, and geopolitical. A certain restoration in normal ties can be seen as inevitable and mutually beneficial. However, the danger lies in India's potential acquiescence to a structural overhaul of economic ties with China, which would leave the latter in an even stronger position to apply economic pressure on India in the future for strategic objectives. India is caught in an unenviable dilemma, where the short-term pain of non-cooperation with China could be acute, but the relief of that pain through wider entry for Chinese companies could lead to long-term structural vulnerabilities.
Nowhere is this more evident than in the example of greater Chinese penetration (through its companies) in the Indian agricultural and horticultural sectors. The dislocations in the Indian automobile sector due to China's export restrictions are already well-reported and discussed. Recently, Bajaj Auto warned that August (2025) may be 'zero month' for the company owing to production-halts resulting from Chinese export restrictions. Given the increasing involvement of Indian automobile companies in defence production, China's new condition of non-dual-use certification could have serious strategic implications for the future as well.
Despite Delhi's structural concerns related to greater economic exchange with China, there are many immediate reasons/triggers why Delhi could still be tempted. These pertain to a worrying trend in terms of declining FDI, hopes for greater inclusion in global supply chains via China linkages, and, most importantly, hopes of persuading Beijing to reverse its economic coercive approach towards India.
Hence, tactical initiatives could end up taking a life of their own, especially given China's ability to exploit India's short-term vulnerabilities to achieve greater stabilisation of its long-term goals. India's patrolling agreement in October last year serves as a key example of the same. India had then hoped for a policy based on greater 'mutual understanding' in exchange for Delhi's willingness to overlook Chinese actions at the LAC since 2020. Instead, the last year has seen even greater Chinese coercion and intransigence driven by assessments of India's weakened geopolitical position and national power.
Whereas both India and China have a strong a priori reason to 'come closer' owing to Trump's 'disruption' and 'unilateralism', it is China that is in the right position to exploit the 'Trump disruption' to meet its strategic objectives vis-à-vis India while also further weakening the US-India strategic partnership.
Sidharth Raimedhi is a Fellow at the Council for Strategic and Defense Research (CSDR), a New Delhi-based think tank. He tweets @SidharthRaimed1. Views are personal.
This article was first published by CSDR.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New 'Khalistan embassy' in Canada threatens India-Canada ties again
New 'Khalistan embassy' in Canada threatens India-Canada ties again

Business Standard

time5 minutes ago

  • Business Standard

New 'Khalistan embassy' in Canada threatens India-Canada ties again

Just as India and Canada were making cautious moves to improve strained ties, visuals of an 'Embassy of the Republic of Khalistan' on Canadian soil have risked derailing hard-earned diplomatic progress. Radical Sikh groups in British Columbia have established what they describe as the 'Embassy of the Republic of Khalistan'. Photographs accessed by India Today show that the self-proclaimed embassy is located inside a section of the Guru Nanak Sikh Gurdwara in Surrey. The same gurdwara was once led by Hardeep Singh Nijjar, a pro-Khalistan figure whom Indian authorities had labelled a terrorist. Nijjar was shot dead in 2023 in the gurdwara's car park, setting off a chain of events that pushed India-Canada relations into a deep freeze. The announcement of the so-called 'embassy' coincides with preparations for a 'Khalistan referendum' organised by Sikhs for Justice (SFJ), a group banned in India. According to reports, Indian security agencies are keeping a close watch. Diplomatic thaw under threat The development comes at a time when ties between the two countries had shown tentative signs of a thaw. Prime Minister Narendra Modi and Canada's newly-elected Prime Minister Mark Carney met face-to-face during the G7 summit earlier this year — their first such meeting since tensions escalated. Both sides had indicated a willingness to move beyond the fallout from Nijjar's killing and the allegations made by former Canadian Prime Minister Justin Trudeau, who had accused the Indian government of involvement in the murder — a charge New Delhi has firmly denied. Canadian intelligence backs India's security concerns India has long raised concerns about Khalistani groups using Canadian soil as a safe haven for promoting separatist ideology, fundraising, and plotting acts of violence. It has consistently criticised Canadian authorities for alleged inaction. In a notable shift, Canadian authorities have acknowledged these concerns. In June 2025, the Canadian Security Intelligence Service (CSIS) officially recognised the threat posed by Khalistani extremists operating within Canada. Its annual report stated: 'Khalistani extremists continue to use Canada as a base for the promotion, fundraising or planning of violence primarily in India.' While no attacks linked to Canada-based Khalistani extremists (CBKEs) occurred in 2024, CSIS warned that such actors remain active in global financing and operational planning. This marked the first time the Canadian government has officially used the term 'extremism' in the context of the Khalistan movement. CSIS described Canada-based Khalistani extremists as a core element of the country's politically motivated violent extremism (PMVE) threat. According to the agency, PMVE groups aim to use violence to create new political systems or structures, often through cross-border efforts. Khalistani actors, the agency warned, continue to engage in 'planning, financing and facilitating attacks globally' in pursuit of a separate Khalistan state, primarily carved out of India's Punjab region.

Britannia Q1 profit misses estimates, sees early signs of urban recovery
Britannia Q1 profit misses estimates, sees early signs of urban recovery

Business Standard

time5 minutes ago

  • Business Standard

Britannia Q1 profit misses estimates, sees early signs of urban recovery

Britannia Industries posted first-quarter profit below estimates on Tuesday, but the Indian biscuit maker said urban consumption - dull for a few quarters - is picking up. The seller of 'Marie Gold' and 'Bourbon' biscuits joins other domestic consumer goods makers such as Hindustan Unilever and ITC in forecasting early signs of a recovery in urban demand, aided by easing local inflation. India's annual retail inflation slowed every month in the quarter, easing to a six-year low in June at 2.1 per cent. That helped spur a "marginal uptick in consumption across both urban and rural markets," said Varun Berry, managing director and chief executive. Britannia's quarterly sales grew 9.8 per cent to ₹4,535 crore ($516.5 million). The firm had previously flagged rise in popular demand for packaged food and confectionery items such as croissants, wafers and flavoured shakes - usually more likely to be bought on impulse. But total spends rose 10.4 per cent, led by a 15 per cent jump in raw material costs. Britannia has been hiking prices to partly offset the higher costs of raw materials such as cocoa, flour and palm oil. Profits in the reported quarter came in at ₹521 crore, up 3 per cent on-year, but below analysts' average estimate of ₹570 crore rupees, according to data compiled by LSEG.

Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26
Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26

Business Standard

time5 minutes ago

  • Business Standard

Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26

Ahmedabad-based Eris Lifesciences is looking to tap opportunities in the nearly Rs 5,000-crore Indian insulin market after Danish drugmaker Novo Nordisk announced the withdrawal of its insulin products from the market in April this year. 'We expect that Novo's cartridge inventory in the market will run out by October 2025. So this market opportunity is something that one can start monetising from the November–December time frame,' the company's executive director and chief executive officer (CEO), Krishnakumar Vaidyanathan, told Business Standard. He added that the timing fits Eris' plans, as the cartridge filling capability of its Bhopal unit will start becoming operational from January. Vial manufacturing has already been commissioned at the unit, with the company creating a strategic stock of insulins. This comes at a time when Eris is already the largest domestic player in insulins. The company had acquired the India formulations business of Biocon Biologics last year — including established insulin brands Basalog and Insugen. 'Before the Biocon deal, we had a couple of homegrown insulin brands in the market, which did a combined Rs 60 crore in revenue last year. Basalog and Insugen had combined revenues of Rs 200 crore at the time of acquisition,' he said. He added that, with this, the company's insulin franchise has become significantly larger, with a 10 per cent market share. Eris is also among the prominent drugmakers looking to roll out generic versions of the blockbuster molecule semaglutide once its patent expires around March next year. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used as an active pharmaceutical ingredient in medications for obesity management and Type-II diabetes. According to Eris' investor presentation for the June quarter of 2025–26 (Q1FY26), the company is on track to be among the first launches in India in March 2026. The company has initiated validation of synthetic semaglutide cartridges at its European Union (EU)-approved AMD injectables site. 'We are also planning the validation of the recombinant semaglutide in our Bhopal plant later this year,' he added. As far as the go-to-market strategy is concerned, the company said it is already in a strong position because of its dominant presence in insulins and prior presence in the GLP market with the launch of liraglutide in September last year. For Q1FY26, Eris Lifesciences recorded a 40 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) to Rs 125 crore. Revenue rose to Rs 773 crore during the June quarter against Rs 720 crore in the year-ago period.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store